Prominent Deep Learning In Drug Discovery And Diagnostics Market Trend for 2025: New Supercomputers Boost AI Capabilities In Drug Discovery And Diagnostics

What Are the Projected Growth and Market Size Trends for the Deep Learning In Drug Discovery And Diagnostics Market?
The market size for deep learning in drug discovery and diagnostics has experienced substantial growth recently. Projected to increase from $8.21 billion in 2024 to $10.58 billion in 2025, it boasts a compound annual growth rate (CAGR) of 28.8%. This expansion during the historic period is credited to an uptick in AI research investments, heightened need for personalized medicine, increased public and private sector funding, a surge in chronic diseases and intricate conditions, and a growing penchant for adopting electronic health records.

Expectations are high for the deep learning in drug discovery and diagnostics market, with predictions of significant expansion in the approaching years. The market is projected to burgeon to a size of $28.82 billion in 2029, displaying a compound annual growth rate (CAGR) of 28.5%. Factors contributing to this predicted increase during the forecast period include enhancements in diagnostic accuracy, collaborations ramping up between technological corporations and pharmaceutical companies, advancements in explainable AI (xai) boosting model transparency, a growing focus on real-world evidence (RWE), and proliferation in burgeoning markets. During the forecast period, notable trends expected to emerge involve the adoption of AI technologies, breakthroughs in computational power, the fusion of big data, invention of new deep learning frameworks, and the growth of cloud platforms for AI.

What Is Driving the Growth Trajectory of the Deep Learning In Drug Discovery And Diagnostics Market?
The surge in demand for personalized medicine is set to bolster the progression of the deep learning market in drug discovery and diagnostics. Personalized medicine utilises individual genetic, environmental, and lifestyle factors to tailor medical treatments and interventions, enhancing efficiency while reducing adverse effects. This increased demand is propelled by advancements in genomics and data analytics, fuelling more accurate and efficient treatments tailored to individual patient needs. Deep learning contributes to drug discovery and diagnostics by analyzing intricate biological data, identifying distinctive biomarkers, and accurately predicting patient responses to treatment. For example, in February 2024, the FDA gave approval to 16 novel personalized therapies for patients suffering from rare diseases in 2023, a substantial increase from six in 2022, according to the Personalized Medicine Coalition, a non-profit organization based in the US. Consequently, the surge in demand for personalized medicine is driving the growth of the deep learning market in drug discovery and diagnostics.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19394&type=smp

Which Leading Companies Are Shaping the Growth of the Deep Learning In Drug Discovery And Diagnostics Market?
Major companies operating in the deep learning in drug discovery and diagnostics market are Google Inc., Microsoft Corporation, International Business Machines Corporation, NVIDIA Corporation, Zebra Medical Vision Ltd., Tempus Labs Inc., Nanostring Technologies Inc., Owkin Inc., Insilico Medicine Inc., SOPHiA GENETICS SA, Qureai Technologies Pvt Ltd., H2Oai Inc., Arterys Inc., Deep Genomics Inc., GNS Healthcare Inc., MedAware Systems Inc., PathAI Inc., Kheiron Medical Technologies Ltd., CureMetrix Inc., OncoImmunity AS, Proscia Inc., BenevolentAI Ltd., BioXcel Therapeutics Inc.

What Are the Major Trends Shaping the Deep Learning In Drug Discovery And Diagnostics Market?
The primary players in the deep learning market for drug discovery and diagnostics are prioritizing the evolution of high-capacity computing technologies such as supercomputers to expedite innovation by enhancing performance and productivity in sophisticated tasks and AI applications. Supercomputers' advancements aid in deep learning for drug discovery and diagnostics by quickening intricate data analysis and simulations, which results in a more rapid pinpointing of drug candidates and more precise diagnostics. For example, in November 2022, Hewlett-Packard Enterprise, a US-based IT firm, launched HPE Cray EX and HPE Cray XD supercomputers. These cutting-edge systems provide efficient performance and large-scale AI capabilities in a more condensed and budget-friendly model, with the aim of hastening drug discovery and treatment for diseases. This technology empowers research scientists and pharmaceutical labs to better understand chemical interactions, promoting the creation of breakthrough drug therapies for both difficult and emerging diseases.

What Are the Key Segments of the Deep Learning In Drug Discovery And Diagnostics Market?
The deep learning in drug discovery and diagnosticsmarket covered in this report is segmented -

1) By Type: Drug Discovery, Diagnostics, Forensic Interventions, Other Types
2) By Drug Type: Small Molecule Drugs, Biologics Drugs
3) By End Use Industry: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Healthcare Information Technology (IT)

Subsegments:
1) By Drug Discovery: Target Identification, Drug Screening, Lead Optimization, Predictive Modeling
2) By Diagnostics: Medical Imaging Analysis, Genomic Data Interpretation, Disease Detection Algorithms, Personalized Medicine
3) By Forensic Interventions: Digital Pathology, Forensic DNA Analysis, Toxicology Screening, Crime Scene Reconstruction
4) By Other Types: Biomarker Discovery, Predictive Analytics in Healthcare, Patient Data Management Systems

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/deep-learning-in-drug-discovery-and-diagnostics-global-market-report

Which Region Dominates the Deep Learning In Drug Discovery And Diagnostics Market?
North America was the largest region in the deep learning in drug discovery and diagnostics market in 2024. The regions covered in the deep learning in drug discovery and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Deep Learning In Drug Discovery And Diagnostics Global Market Report?

- Market Size Analysis: Analyze the Deep Learning In Drug Discovery And Diagnostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Deep Learning In Drug Discovery And Diagnostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Deep Learning In Drug Discovery And Diagnostics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Deep Learning In Drug Discovery And Diagnostics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19394

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.